Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms.
The impetus for discovery and evaluation of protein biomarkers has been accelerated by recent development of advanced technologies for rapid and broad proteome analyses. Mass spectrometry (MS)-based protein assays hold great potential for in vitro biomarker studies. Described here is the development of a multiplex mass spectrometric immunoassay (MSIA) for quantification of apolipoprotein C-I (apoC-I), apolipoprotein C-II (apoC-II), apolipoprotein C-III (apoC-III) and their proteoforms. The multiplex MSIA assay was fast (∼ 40 min) and high-throughput (96 samples at a time). The assay was applied to a small cohort of human plasma samples, revealing the existence of multiple proteoforms for each apolipoprotein C. The quantitative aspect of the assay enabled determination of the concentration for each proteoform individually. Low-abundance proteoforms, such as fucosylated apoC-III, were detected in less than 20% of the samples. The distribution of apoC-III proteoforms varied among samples with similar total apoC-III concentrations. The multiplex analysis of the three apolipoproteins C and their proteoforms using quantitative MSIA represents a significant step forward toward better understanding of their physiological roles in health and disease.
The Biodesign Institute at Arizona State University, Tempe, AZ 85287, United States.
Olgica
O
Trenchevska
The Biodesign Institute at Arizona State University, Tempe, AZ 85287, United States.
Matthew R
MR
Schaab
The Biodesign Institute at Arizona State University, Tempe, AZ 85287, United States.
Randall W
RW
Nelson
The Biodesign Institute at Arizona State University, Tempe, AZ 85287, United States. Electronic address: dobrin.nedelkov@asu.edu.
Dobrin
D
Nedelkov
D053302:Apolipoprotein C-I / Q000097:blood* / Q000378:metabolism; D053304:Apolipoprotein C-II / Q000097:blood* / Q000378:metabolism; D053305:Apolipoprotein C-III / Q000097:blood* / Q000378:metabolism; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D013058:Mass Spectrometry / Q000379:methods*; D020033:Protein Isoforms / Q000097:blood / Q000378:metabolism; D011499:Protein Processing, Post-Translational
D053302:Apolipoprotein C-I; D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D020033:Protein Isoforms
Apolipoprotein C-I, C-II, C-III; Biomarkers; Mass spectrometric immunoassay; Proteoforms; Quantification